Actavis Fentanyl Patch Recall: Risk of Overdose and Death. Yet another fentanyl patch recall has been issued after a drug maker discovered that some of their pain patches could release lethal amounts of the powerful painkiller into the user’s bloodstream. If too much fentanyl is delivered, the pain patches could cause patients to suffer excessive sedation, respiratory depression, slow breathing to dangerous levels or temporarily stop breathing. Actavis said it is not aware of any injuries in connection to the defective pain patches. The recall affects 1. Actavis Fentanyl Transdermal System 2. C- II patches at the wholesale and retail level. The patches were packaged individually and shipped in boxes of five. The defective patches were manufactured for Actavis by Corium International in Grand Rapids, Michigan. FDA Announces Fentanyl Transdermal System Recall. 30041, Exp 12/2011 30258, Exp 03/2012. A fentanyl patch lawsuit has been filed by a West Virginia woman who allegedly went comatose after wearing a generic version of a pain patch manufactured by Mylan. The FDA has issued a recall of certain lots of Actavis Fentanyl Transdermal System (25 mcg) due to the potential for the active ingredient to release faster than. There is a Control/Lot number on the bottom of each box and on the black and white side of each individual package in the lower left corner. The recalled lot numbers are 3. The Actavis fentanyl pain patch is a generic version of the Duragesic patch, which is manufactured by a subsidiary of Johnson & Johnson. Fentanyl Transdermal official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Yet another Duragesic. A division of Ortho-McNeil Janssen Pharmaceuticals named PriCara voluntarily recalled two lots of 50. Another fentanyl patch recall has been issued after it was discovered that some of their pain patches could release lethal amounts of the powerful painkiller into the. The fentanyl patch is prescribed to patients suffering from chronic, severe pain. It is designed to slowly deliver a dose of the powerful painkiller Fentanyl, which is an opioid that is considered 1. If too much of the medication is delivered or if the fentanyl gel contained in the patch comes in direct contact with the skin, it can cause a fatal fentanyl patch overdose. Since the Duragesic patch was first introduced by Johnson & Johnson in 1. At least seven different recalls of fentanyl patch systems have been issued by Johnson & Johnson and companies manufacturing generic versions of the patch, raising questions about whether the powerful painkiller can be safely made. Hundreds of fentanyl pain patch overdose deaths have been associated with different versions of the patch, and dozens of fentanyl patch wrongful death lawsuits have been filed against the various manufacturers. Actavis has asked all wholesalers and retailers to return the product they have in stock. Any adverse reactions should be reported to FDA. Tags: Actavis, Duragesic, Fentanyl, Fentanyl Patch, Fentanyl Patch Recall, Johnson & Johnson, Michigan, Overdose. Fentanyl Transdermal System Patch Recall. The following information is from Watson Pharmaceuticals, Inc. Contact the company for a copy of any referenced. Actavis Fentanyl Recall – Recall Update for Consumers October 21, 2010 ACTAVIS FENTANYL RECALL U.S. Fentanyl Recall Information – Important Update for.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2016
Categories |